Skip to main content
OpenTrials

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

9,146 public trials 1,794 recruiting studies
Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Recruiting

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

NCT07174310

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • Neurology Center of North Orange County Fullerton, California, United States
  • UC San Diego La Jolla, California, United States
View all 192 locations
View Trial Details
Recruiting

Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy

NCT07461220

Conditions
Apathy, Basal Ganglia Diseases, Brain Diseases, +14 more
Locations
  • Medical Center "Galileo" OOD Pleven, Bulgaria
  • First University Multiprofile Hospital for Active Treatment MHAT - Neurology Clinic Sofia, Bulgaria
  • University Multiprofile Hospital for Active Treatment "Alexandrovska" EAD, Clinic of Neurological Diseases Sofia, Bulgaria
  • Neurologie Berlin Berlin, Germany
View all 14 locations
View Trial Details
Recruiting

Deep Brain Stimulation (DBS) Retrospective Outcomes Study

NCT03664609

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +12 more
Locations
  • St. Joseph's Hospital & Medical Center Phoenix, Arizona, United States
  • University of California, San Francisco San Francisco, California, United States
  • University of Miami Hospital Miami, Florida, United States
  • University of South Florida Tampa, Florida, United States
View all 20 locations
View Trial Details
Recruiting

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

NCT04374305

Conditions
Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +38 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • University of Miami Miami, Florida, United States
  • Indiana University School of Medicine Indianopolis, Indiana, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
View Trial Details

Related conditions